Review Article
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery: An Update Meta-Analysis and Trial Sequential Analysis
Table 3
Stratified analyses of levosimendan administration and surgical type.
| Group | Number of studies | 95% CI | (heterogeneity) | (%) | (overall effect) |
| Timing and dose of infusion of levosimendan | | | | | | Bolus + 24-hour prolonged infusion | 7 | 0.48 [0.32, 0.73] | 0.62 | 0 | 0.0004 | No bolus + 24-hour prolonged infusion | 5 | 0.79 [0.41, 1.53] | 0.43 | 0 | 0.49 | No bolus + unclear duration | 3 | 0.35 [0.13, 1.00] | 0.72 | 0 | 0.05 | Type of cardiac surgery | | | | | | Coronary surgery | 10 | 0.56 [0.35, 0.90] | 0.58 | 0 | 0.02 | Other cardiac surgeries | 5 | 0.50 [0.32, 0.78] | 0.47 | 0 | 0.002 |
|
|